Correction: Pandey et al. ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer. Cancers 2019, 11, 718
Error in Figure
Reference
- Pandey, G.; Borcherding, N.; Kolb, R.; Kluz, P.; Li, W.; Sugg, S.; Zhang, J.; Lai, D.A.; Zhang, W. ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer. Cancers 2019, 11, 718. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pandey, G.; Borcherding, N.; Kolb, R.; Kluz, P.; Li, W.; Sugg, S.; Zhang, J.; Lai, D.A.; Zhang, W. Correction: Pandey et al. ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer. Cancers 2019, 11, 718. Cancers 2022, 14, 4529. https://doi.org/10.3390/cancers14184529
Pandey G, Borcherding N, Kolb R, Kluz P, Li W, Sugg S, Zhang J, Lai DA, Zhang W. Correction: Pandey et al. ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer. Cancers 2019, 11, 718. Cancers. 2022; 14(18):4529. https://doi.org/10.3390/cancers14184529
Chicago/Turabian StylePandey, Gaurav, Nicholas Borcherding, Ryan Kolb, Paige Kluz, Wei Li, Sonia Sugg, Jun Zhang, Dazhi A. Lai, and Weizhou Zhang. 2022. "Correction: Pandey et al. ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer. Cancers 2019, 11, 718" Cancers 14, no. 18: 4529. https://doi.org/10.3390/cancers14184529
APA StylePandey, G., Borcherding, N., Kolb, R., Kluz, P., Li, W., Sugg, S., Zhang, J., Lai, D. A., & Zhang, W. (2022). Correction: Pandey et al. ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer. Cancers 2019, 11, 718. Cancers, 14(18), 4529. https://doi.org/10.3390/cancers14184529